Drug Pipeline

Oregovomab Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
4
Active Studies
0
Recruiting
1
Phase 3
1
Top Sponsors
Active Studies by Phase
Phase 3
1
Phase 2
2
Phase 1/2
1
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT04498117 Oregovomab Plus Chemo in Newly Diagnosed Patients With Advanced Epithelial Ovarian Cancer… Carcinoma, Ovarian Epithelial Active, Not Recruiting
Phase 2
NCT05605535 Oregovomab Plus Chemotherapy in Neo-adjuvant Setting in Newly Diagnosed Patients With… Ovarian Neoplasm Epithelial Active, Not Recruiting
NCT05335993 A Clinical Study Evaluating a Combination of Oregovomab and Niraparib in Adult Women With… Recurrent Ovarian Cancer Active, Not Recruiting
Phase 1/2
NCT04938583 Oregovomab in Combination With Bevacizumab Plus Chemo in BRCA Wild Type Platinum… Ovarian Cancer by FIGO Stage Active, Not Recruiting
Sponsors Running Oregovomab Trials
Disease Areas
Get alerts when Oregovomab trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free